Sublimity Therapeutics is Drug Discovery in Ireland that focus on proprietary technology business. Founded in 2003. They cover business area such as developer, an oral drug delivery technology, therapy, gastrointestinal and immunological disease, disorder, oral delivery, difficult-to-formulate drug, issue, solubility, permeability, client, oral drug formulation, both small and large molecule, potentially biologic, antibody.
2003
( 21 years old in 2024 )
Proprietary Technology
-
DCU Alpha Innovation Campus
Old Finglas Road
Dublin D11 KXN4
Ireland
Private
developeran oral drug delivery technologytherapygastrointestinal and immunological diseasedisorderoral deliverydifficult-to-formulate drugissuesolubilitypermeabilityclientoral drug formulationboth small and large moleculepotentially biologicantibody
* We use standard office opening hours in near Sublimity Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Sublimity Therapeutics is Drug Discovery business from Ireland that founded in 2003 (21 years old in 2024), Sublimity Therapeutics business is focusing on Proprietary Technology.
Sublimity Therapeutics headquarter office and corporate office address is located in DCU Alpha Innovation Campus Old Finglas Road Dublin D11 KXN4 Ireland.
Sublimity Therapeutics was founded in Ireland.
In 2024, Sublimity Therapeutics is currently focus on proprietary technology sector.
Above is snippet of Google Trends for "proprietary technology" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Sublimity Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
